nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—BCHE—Ramipril—type 2 diabetes mellitus	0.285	1	CbGbCtD
Aclidinium—Toothache—Sitagliptin—type 2 diabetes mellitus	0.00845	0.0192	CcSEcCtD
Aclidinium—Cardio-respiratory arrest—Irbesartan—type 2 diabetes mellitus	0.00844	0.0192	CcSEcCtD
Aclidinium—Diabetes mellitus—Linagliptin—type 2 diabetes mellitus	0.00688	0.0156	CcSEcCtD
Aclidinium—Toothache—Gliclazide—type 2 diabetes mellitus	0.00627	0.0142	CcSEcCtD
Aclidinium—Osteoarthritis—Nateglinide—type 2 diabetes mellitus	0.0056	0.0127	CcSEcCtD
Aclidinium—Nasopharyngitis—Linagliptin—type 2 diabetes mellitus	0.00535	0.0121	CcSEcCtD
Aclidinium—Diabetes mellitus—Rosiglitazone—type 2 diabetes mellitus	0.00527	0.012	CcSEcCtD
Aclidinium—Toothache—Metformin—type 2 diabetes mellitus	0.00525	0.0119	CcSEcCtD
Aclidinium—Cardiac failure—Rosiglitazone—type 2 diabetes mellitus	0.00469	0.0107	CcSEcCtD
Aclidinium—Toothache—Losartan—type 2 diabetes mellitus	0.00466	0.0106	CcSEcCtD
Aclidinium—Infestation—Linagliptin—type 2 diabetes mellitus	0.00461	0.0105	CcSEcCtD
Aclidinium—Infestation NOS—Linagliptin—type 2 diabetes mellitus	0.00461	0.0105	CcSEcCtD
Aclidinium—Diabetes mellitus—Pioglitazone—type 2 diabetes mellitus	0.00442	0.01	CcSEcCtD
Aclidinium—Diabetes mellitus—Glimepiride—type 2 diabetes mellitus	0.0043	0.00977	CcSEcCtD
Aclidinium—Nasopharyngitis—Rosiglitazone—type 2 diabetes mellitus	0.0041	0.0093	CcSEcCtD
Aclidinium—Cardiac failure—Pioglitazone—type 2 diabetes mellitus	0.00394	0.00894	CcSEcCtD
Aclidinium—Diabetes mellitus—Bromocriptine—type 2 diabetes mellitus	0.00388	0.00881	CcSEcCtD
Aclidinium—Osteoarthritis—Sitagliptin—type 2 diabetes mellitus	0.00373	0.00847	CcSEcCtD
Aclidinium—Mediastinal disorder—Linagliptin—type 2 diabetes mellitus	0.00373	0.00847	CcSEcCtD
Aclidinium—Sinusitis—Repaglinide—type 2 diabetes mellitus	0.0035	0.00796	CcSEcCtD
Aclidinium—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.00336	0.00763	CcSEcCtD
Aclidinium—Nasopharyngitis—Sitagliptin—type 2 diabetes mellitus	0.00333	0.00757	CcSEcCtD
Aclidinium—Sinusitis—Rosiglitazone—type 2 diabetes mellitus	0.00331	0.00752	CcSEcCtD
Aclidinium—Urinary retention—Bromocriptine—type 2 diabetes mellitus	0.00321	0.00729	CcSEcCtD
Aclidinium—Cough—Linagliptin—type 2 diabetes mellitus	0.00314	0.00714	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.00313	0.00712	CcSEcCtD
Aclidinium—Eye disorder—Repaglinide—type 2 diabetes mellitus	0.00313	0.00711	CcSEcCtD
Aclidinium—Nasopharyngitis—Bromocriptine—type 2 diabetes mellitus	0.00302	0.00685	CcSEcCtD
Aclidinium—Eye disorder—Rosiglitazone—type 2 diabetes mellitus	0.00296	0.00672	CcSEcCtD
Aclidinium—Infestation—Pioglitazone—type 2 diabetes mellitus	0.00296	0.00672	CcSEcCtD
Aclidinium—Infestation NOS—Pioglitazone—type 2 diabetes mellitus	0.00296	0.00672	CcSEcCtD
Aclidinium—Cough—Nateglinide—type 2 diabetes mellitus	0.00294	0.00668	CcSEcCtD
Aclidinium—Infection—Linagliptin—type 2 diabetes mellitus	0.00292	0.00663	CcSEcCtD
Aclidinium—Diabetes mellitus—Orlistat—type 2 diabetes mellitus	0.00289	0.00657	CcSEcCtD
Aclidinium—Infestation NOS—Sitagliptin—type 2 diabetes mellitus	0.00287	0.00653	CcSEcCtD
Aclidinium—Infestation—Sitagliptin—type 2 diabetes mellitus	0.00287	0.00653	CcSEcCtD
Aclidinium—Cardiac failure—Gliclazide—type 2 diabetes mellitus	0.00284	0.00645	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.00282	0.0064	CcSEcCtD
Aclidinium—Rhinitis—Glipizide—type 2 diabetes mellitus	0.00278	0.00631	CcSEcCtD
Aclidinium—Sinusitis—Pioglitazone—type 2 diabetes mellitus	0.00278	0.00631	CcSEcCtD
Aclidinium—Osteoarthritis—Gliclazide—type 2 diabetes mellitus	0.00277	0.00629	CcSEcCtD
Aclidinium—Sinusitis—Sitagliptin—type 2 diabetes mellitus	0.0027	0.00612	CcSEcCtD
Aclidinium—Urinary tract disorder—Pioglitazone—type 2 diabetes mellitus	0.00262	0.00596	CcSEcCtD
Aclidinium—Cardiac failure—Valsartan—type 2 diabetes mellitus	0.00261	0.00592	CcSEcCtD
Aclidinium—Urethral disorder—Pioglitazone—type 2 diabetes mellitus	0.0026	0.00591	CcSEcCtD
Aclidinium—Eye disorder—Glipizide—type 2 diabetes mellitus	0.00259	0.00589	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.00256	0.00582	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.00256	0.00582	CcSEcCtD
Aclidinium—Urinary tract disorder—Sitagliptin—type 2 diabetes mellitus	0.00255	0.00579	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.00254	0.00576	CcSEcCtD
Aclidinium—Urethral disorder—Sitagliptin—type 2 diabetes mellitus	0.00253	0.00574	CcSEcCtD
Aclidinium—Osteoarthritis—Orlistat—type 2 diabetes mellitus	0.00252	0.00571	CcSEcCtD
Aclidinium—Diabetes mellitus—Irbesartan—type 2 diabetes mellitus	0.00251	0.00571	CcSEcCtD
Aclidinium—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00248	0.00564	CcSEcCtD
Aclidinium—Eye disorder—Pioglitazone—type 2 diabetes mellitus	0.00248	0.00564	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.00246	0.00559	CcSEcCtD
Aclidinium—Sinusitis—Bromocriptine—type 2 diabetes mellitus	0.00244	0.00554	CcSEcCtD
Aclidinium—Eye disorder—Sitagliptin—type 2 diabetes mellitus	0.00241	0.00548	CcSEcCtD
Aclidinium—Mediastinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00239	0.00544	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.00238	0.00539	CcSEcCtD
Aclidinium—Diabetes mellitus—Losartan—type 2 diabetes mellitus	0.00237	0.00537	CcSEcCtD
Aclidinium—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.00234	0.00532	CcSEcCtD
Aclidinium—Mediastinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00233	0.00528	CcSEcCtD
Aclidinium—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00228	0.00517	CcSEcCtD
Aclidinium—Infection—Rosiglitazone—type 2 diabetes mellitus	0.00224	0.00508	CcSEcCtD
Aclidinium—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00221	0.00501	CcSEcCtD
Aclidinium—Eye disorder—Bromocriptine—type 2 diabetes mellitus	0.00218	0.00496	CcSEcCtD
Aclidinium—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00212	0.00482	CcSEcCtD
Aclidinium—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00212	0.00481	CcSEcCtD
Aclidinium—Mediastinal disorder—Bromocriptine—type 2 diabetes mellitus	0.0021	0.00478	CcSEcCtD
Aclidinium—Nasopharyngitis—Metformin—type 2 diabetes mellitus	0.00207	0.00471	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.00206	0.00467	CcSEcCtD
Aclidinium—Headache—Tolbutamide—type 2 diabetes mellitus	0.00205	0.00464	CcSEcCtD
Aclidinium—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00203	0.00461	CcSEcCtD
Aclidinium—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00201	0.00457	CcSEcCtD
Aclidinium—Sinusitis—Gliclazide—type 2 diabetes mellitus	0.002	0.00455	CcSEcCtD
Aclidinium—Eye disorder—Glyburide—type 2 diabetes mellitus	0.00199	0.00453	CcSEcCtD
Aclidinium—Infestation—Valsartan—type 2 diabetes mellitus	0.00196	0.00445	CcSEcCtD
Aclidinium—Infestation NOS—Valsartan—type 2 diabetes mellitus	0.00196	0.00445	CcSEcCtD
Aclidinium—Cough—Sitagliptin—type 2 diabetes mellitus	0.00196	0.00445	CcSEcCtD
Aclidinium—Nasopharyngitis—Irbesartan—type 2 diabetes mellitus	0.00196	0.00444	CcSEcCtD
Aclidinium—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00195	0.00443	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00194	0.00441	CcSEcCtD
Aclidinium—Infestation NOS—Orlistat—type 2 diabetes mellitus	0.00194	0.0044	CcSEcCtD
Aclidinium—Infestation—Orlistat—type 2 diabetes mellitus	0.00194	0.0044	CcSEcCtD
Aclidinium—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.00192	0.00436	CcSEcCtD
Aclidinium—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00192	0.00435	CcSEcCtD
Aclidinium—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00189	0.00429	CcSEcCtD
Aclidinium—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00188	0.00428	CcSEcCtD
Aclidinium—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00188	0.00426	CcSEcCtD
Aclidinium—Infection—Pioglitazone—type 2 diabetes mellitus	0.00188	0.00426	CcSEcCtD
Aclidinium—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.00187	0.00425	CcSEcCtD
Aclidinium—Headache—Tolazamide—type 2 diabetes mellitus	0.00186	0.00423	CcSEcCtD
Aclidinium—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00186	0.00423	CcSEcCtD
Aclidinium—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00185	0.0042	CcSEcCtD
Aclidinium—Headache—Linagliptin—type 2 diabetes mellitus	0.00184	0.00418	CcSEcCtD
Aclidinium—Sinusitis—Valsartan—type 2 diabetes mellitus	0.00184	0.00418	CcSEcCtD
Aclidinium—Infection—Sitagliptin—type 2 diabetes mellitus	0.00182	0.00414	CcSEcCtD
Aclidinium—Sinusitis—Orlistat—type 2 diabetes mellitus	0.00182	0.00413	CcSEcCtD
Aclidinium—Vomiting—Acarbose—type 2 diabetes mellitus	0.00181	0.00412	CcSEcCtD
Aclidinium—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.00181	0.00411	CcSEcCtD
Aclidinium—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.0018	0.00408	CcSEcCtD
Aclidinium—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00179	0.00408	CcSEcCtD
Aclidinium—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.00179	0.00407	CcSEcCtD
Aclidinium—Infestation—Metformin—type 2 diabetes mellitus	0.00179	0.00406	CcSEcCtD
Aclidinium—Infestation NOS—Metformin—type 2 diabetes mellitus	0.00179	0.00406	CcSEcCtD
Aclidinium—Rhinitis—Valsartan—type 2 diabetes mellitus	0.00177	0.00401	CcSEcCtD
Aclidinium—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00175	0.00398	CcSEcCtD
Aclidinium—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00175	0.00397	CcSEcCtD
Aclidinium—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.00174	0.00395	CcSEcCtD
Aclidinium—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.00173	0.00392	CcSEcCtD
Aclidinium—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.00172	0.0039	CcSEcCtD
Aclidinium—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.00171	0.00387	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.0017	0.00386	CcSEcCtD
Aclidinium—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00169	0.00384	CcSEcCtD
Aclidinium—Infection—Bromocriptine—type 2 diabetes mellitus	0.00165	0.00374	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00163	0.0037	CcSEcCtD
Aclidinium—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00163	0.0037	CcSEcCtD
Aclidinium—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00163	0.00369	CcSEcCtD
Aclidinium—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00162	0.00368	CcSEcCtD
Aclidinium—Rhinitis—Metformin—type 2 diabetes mellitus	0.00161	0.00365	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00159	0.00361	CcSEcCtD
Aclidinium—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.00159	0.0036	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00158	0.00359	CcSEcCtD
Aclidinium—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.00157	0.00356	CcSEcCtD
Aclidinium—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00154	0.0035	CcSEcCtD
Aclidinium—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.00152	0.00345	CcSEcCtD
Aclidinium—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00151	0.00344	CcSEcCtD
Aclidinium—Eye disorder—Metformin—type 2 diabetes mellitus	0.0015	0.0034	CcSEcCtD
Aclidinium—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.00149	0.00339	CcSEcCtD
Aclidinium—Headache—Repaglinide—type 2 diabetes mellitus	0.00149	0.00339	CcSEcCtD
Aclidinium—Sinusitis—Losartan—type 2 diabetes mellitus	0.00149	0.00338	CcSEcCtD
Aclidinium—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00149	0.00338	CcSEcCtD
Aclidinium—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.00148	0.00337	CcSEcCtD
Aclidinium—Cough—Gliclazide—type 2 diabetes mellitus	0.00146	0.00331	CcSEcCtD
Aclidinium—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.00145	0.00328	CcSEcCtD
Aclidinium—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00144	0.00328	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00143	0.00325	CcSEcCtD
Aclidinium—Rhinitis—Losartan—type 2 diabetes mellitus	0.00143	0.00324	CcSEcCtD
Aclidinium—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00143	0.00324	CcSEcCtD
Aclidinium—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00141	0.0032	CcSEcCtD
Aclidinium—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00139	0.00315	CcSEcCtD
Aclidinium—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.00136	0.0031	CcSEcCtD
Aclidinium—Infection—Gliclazide—type 2 diabetes mellitus	0.00135	0.00307	CcSEcCtD
Aclidinium—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00135	0.00306	CcSEcCtD
Aclidinium—Cough—Valsartan—type 2 diabetes mellitus	0.00134	0.00304	CcSEcCtD
Aclidinium—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00134	0.00303	CcSEcCtD
Aclidinium—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00133	0.00302	CcSEcCtD
Aclidinium—Cough—Orlistat—type 2 diabetes mellitus	0.00132	0.003	CcSEcCtD
Aclidinium—Vision blurred—Metformin—type 2 diabetes mellitus	0.00132	0.00299	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00131	0.00297	CcSEcCtD
Aclidinium—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00129	0.00293	CcSEcCtD
Aclidinium—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00128	0.0029	CcSEcCtD
Aclidinium—Sinusitis—Ramipril—type 2 diabetes mellitus	0.00128	0.0029	CcSEcCtD
Aclidinium—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00126	0.00286	CcSEcCtD
Aclidinium—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00126	0.00286	CcSEcCtD
Aclidinium—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00125	0.00285	CcSEcCtD
Aclidinium—Vomiting—Glipizide—type 2 diabetes mellitus	0.00125	0.00285	CcSEcCtD
Aclidinium—Infection—Valsartan—type 2 diabetes mellitus	0.00124	0.00282	CcSEcCtD
Aclidinium—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00124	0.00282	CcSEcCtD
Aclidinium—Headache—Glipizide—type 2 diabetes mellitus	0.00123	0.0028	CcSEcCtD
Aclidinium—Infection—Orlistat—type 2 diabetes mellitus	0.00123	0.00279	CcSEcCtD
Aclidinium—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00123	0.00279	CcSEcCtD
Aclidinium—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00121	0.00275	CcSEcCtD
Aclidinium—Headache—Pioglitazone—type 2 diabetes mellitus	0.00118	0.00269	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00118	0.00267	CcSEcCtD
Aclidinium—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00117	0.00266	CcSEcCtD
Aclidinium—Vision blurred—Losartan—type 2 diabetes mellitus	0.00117	0.00265	CcSEcCtD
Aclidinium—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00117	0.00265	CcSEcCtD
Aclidinium—Headache—Glimepiride—type 2 diabetes mellitus	0.00115	0.00262	CcSEcCtD
Aclidinium—Cough—Irbesartan—type 2 diabetes mellitus	0.00115	0.00261	CcSEcCtD
Aclidinium—Headache—Sitagliptin—type 2 diabetes mellitus	0.00115	0.00261	CcSEcCtD
Aclidinium—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00258	CcSEcCtD
Aclidinium—Infection—Metformin—type 2 diabetes mellitus	0.00113	0.00257	CcSEcCtD
Aclidinium—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00112	0.00254	CcSEcCtD
Aclidinium—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.0011	0.0025	CcSEcCtD
Aclidinium—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.0011	0.00249	CcSEcCtD
Aclidinium—Cough—Losartan—type 2 diabetes mellitus	0.00108	0.00246	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00108	0.00245	CcSEcCtD
Aclidinium—Infection—Irbesartan—type 2 diabetes mellitus	0.00107	0.00243	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00107	0.00242	CcSEcCtD
Aclidinium—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00105	0.0024	CcSEcCtD
Aclidinium—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00105	0.00239	CcSEcCtD
Aclidinium—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00105	0.00238	CcSEcCtD
Aclidinium—Headache—Bromocriptine—type 2 diabetes mellitus	0.00104	0.00236	CcSEcCtD
Aclidinium—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00104	0.00236	CcSEcCtD
Aclidinium—Dry mouth—Losartan—type 2 diabetes mellitus	0.00103	0.00234	CcSEcCtD
Aclidinium—Infection—Losartan—type 2 diabetes mellitus	0.00101	0.00228	CcSEcCtD
Aclidinium—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000992	0.00225	CcSEcCtD
Aclidinium—Tachycardia—Losartan—type 2 diabetes mellitus	0.000987	0.00224	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000984	0.00223	CcSEcCtD
Aclidinium—Vomiting—Glyburide—type 2 diabetes mellitus	0.000964	0.00219	CcSEcCtD
Aclidinium—Headache—Glyburide—type 2 diabetes mellitus	0.00095	0.00216	CcSEcCtD
Aclidinium—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000932	0.00212	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000928	0.00211	CcSEcCtD
Aclidinium—Cough—Ramipril—type 2 diabetes mellitus	0.000928	0.00211	CcSEcCtD
Aclidinium—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000885	0.00201	CcSEcCtD
Aclidinium—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000866	0.00197	CcSEcCtD
Aclidinium—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000856	0.00194	CcSEcCtD
Aclidinium—Headache—Gliclazide—type 2 diabetes mellitus	0.000853	0.00194	CcSEcCtD
Aclidinium—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000851	0.00193	CcSEcCtD
Aclidinium—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000847	0.00192	CcSEcCtD
Aclidinium—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000846	0.00192	CcSEcCtD
Aclidinium—Vomiting—Valsartan—type 2 diabetes mellitus	0.000795	0.00181	CcSEcCtD
Aclidinium—Vomiting—Orlistat—type 2 diabetes mellitus	0.000786	0.00178	CcSEcCtD
Aclidinium—Headache—Valsartan—type 2 diabetes mellitus	0.000784	0.00178	CcSEcCtD
Aclidinium—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000779	0.00177	CcSEcCtD
Aclidinium—Headache—Orlistat—type 2 diabetes mellitus	0.000774	0.00176	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000749	0.0017	CcSEcCtD
Aclidinium—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000736	0.00167	CcSEcCtD
Aclidinium—Vomiting—Metformin—type 2 diabetes mellitus	0.000724	0.00164	CcSEcCtD
Aclidinium—Headache—Metformin—type 2 diabetes mellitus	0.000714	0.00162	CcSEcCtD
Aclidinium—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000692	0.00157	CcSEcCtD
Aclidinium—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000684	0.00155	CcSEcCtD
Aclidinium—Headache—Irbesartan—type 2 diabetes mellitus	0.000674	0.00153	CcSEcCtD
Aclidinium—Vomiting—Losartan—type 2 diabetes mellitus	0.000643	0.00146	CcSEcCtD
Aclidinium—Headache—Losartan—type 2 diabetes mellitus	0.000634	0.00144	CcSEcCtD
Aclidinium—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000594	0.00135	CcSEcCtD
Aclidinium—Vomiting—Ramipril—type 2 diabetes mellitus	0.000552	0.00125	CcSEcCtD
Aclidinium—Headache—Ramipril—type 2 diabetes mellitus	0.000544	0.00123	CcSEcCtD
Aclidinium—Tiotropium—CYP3A4—type 2 diabetes mellitus	0.000362	1	CrCbGaD
Aclidinium—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.37e-05	0.000123	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.36e-05	0.000122	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	3.36e-05	0.000122	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	3.35e-05	0.000122	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.34e-05	0.000122	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—C3—type 2 diabetes mellitus	3.34e-05	0.000122	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.33e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	3.33e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.33e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.33e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.32e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.32e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	3.32e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AGT—type 2 diabetes mellitus	3.31e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.28e-05	0.00012	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.28e-05	0.00012	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.27e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.26e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.26e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	3.26e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.26e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.25e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—LEP—type 2 diabetes mellitus	3.25e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOE—type 2 diabetes mellitus	3.25e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.23e-05	0.000118	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.22e-05	0.000117	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.21e-05	0.000117	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.18e-05	0.000116	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.18e-05	0.000116	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AGT—type 2 diabetes mellitus	3.17e-05	0.000116	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	3.17e-05	0.000115	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.12e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.11e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	3.11e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—LEP—type 2 diabetes mellitus	3.11e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOE—type 2 diabetes mellitus	3.11e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.1e-05	0.000113	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.07e-05	0.000112	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.07e-05	0.000112	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.06e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.06e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.06e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.05e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	3.05e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.05e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	3.04e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.02e-05	0.00011	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.02e-05	0.00011	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	2.96e-05	0.000108	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	2.96e-05	0.000108	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.93e-05	0.000107	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	2.92e-05	0.000106	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—INS—type 2 diabetes mellitus	2.9e-05	0.000106	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.9e-05	0.000105	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.89e-05	0.000105	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.89e-05	0.000105	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.87e-05	0.000104	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.86e-05	0.000104	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.86e-05	0.000104	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.83e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.83e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.83e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	2.82e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.82e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.82e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.81e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.8e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	2.8e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.8e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.79e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.79e-05	0.000102	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.78e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.78e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—INS—type 2 diabetes mellitus	2.77e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.77e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.77e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.77e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	2.75e-05	0.0001	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.74e-05	9.98e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.73e-05	9.96e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.73e-05	9.93e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	2.73e-05	9.92e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.72e-05	9.92e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.71e-05	9.88e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.7e-05	9.83e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.69e-05	9.8e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.69e-05	9.79e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.68e-05	9.77e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.68e-05	9.77e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.68e-05	9.76e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.67e-05	9.72e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	2.66e-05	9.7e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALB—type 2 diabetes mellitus	2.66e-05	9.68e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.66e-05	9.67e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—INS—type 2 diabetes mellitus	2.66e-05	9.67e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-05	9.53e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.61e-05	9.51e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.61e-05	9.51e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	2.61e-05	9.5e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	2.6e-05	9.48e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-05	9.39e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.58e-05	9.38e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.57e-05	9.35e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.57e-05	9.35e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.56e-05	9.31e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.56e-05	9.31e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.55e-05	9.28e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.55e-05	9.27e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.54e-05	9.26e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	2.54e-05	9.26e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.52e-05	9.19e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.45e-05	8.92e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.44e-05	8.89e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.44e-05	8.88e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.43e-05	8.85e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.43e-05	8.85e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.42e-05	8.81e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.41e-05	8.76e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.4e-05	8.73e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.37e-05	8.65e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	2.35e-05	8.56e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	2.34e-05	8.53e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.33e-05	8.48e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.33e-05	8.48e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.33e-05	8.47e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	2.32e-05	8.45e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RELA—type 2 diabetes mellitus	2.29e-05	8.33e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	2.27e-05	8.27e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.24e-05	8.16e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.24e-05	8.14e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.24e-05	8.14e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.23e-05	8.13e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.23e-05	8.12e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—INS—type 2 diabetes mellitus	2.23e-05	8.12e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	2.23e-05	8.11e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.21e-05	8.06e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.21e-05	8.04e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.21e-05	8.03e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.2e-05	8e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	2.19e-05	7.98e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.19e-05	7.97e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.19e-05	7.97e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.19e-05	7.97e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	2.18e-05	7.94e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	2.18e-05	7.94e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.17e-05	7.89e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.16e-05	7.88e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.16e-05	7.87e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.16e-05	7.87e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.16e-05	7.85e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.14e-05	7.78e-05	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.08e-05	7.59e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.06e-05	7.52e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.06e-05	7.52e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.06e-05	7.49e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.05e-05	7.47e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	2.04e-05	7.44e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.04e-05	7.42e-05	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2e-05	7.27e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.98e-05	7.2e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.96e-05	7.15e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	1.95e-05	7.12e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.95e-05	7.12e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.95e-05	7.11e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.95e-05	7.1e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.95e-05	7.09e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.93e-05	7.03e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.93e-05	7.02e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.89e-05	6.89e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.87e-05	6.81e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.87e-05	6.8e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	1.86e-05	6.79e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.85e-05	6.73e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.85e-05	6.72e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.84e-05	6.7e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.83e-05	6.68e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.82e-05	6.61e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.81e-05	6.6e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.81e-05	6.59e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.81e-05	6.58e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.8e-05	6.56e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.8e-05	6.56e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.8e-05	6.55e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	1.8e-05	6.55e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.79e-05	6.53e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-05	6.51e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.79e-05	6.5e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.78e-05	6.5e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.78e-05	6.47e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.75e-05	6.38e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	1.72e-05	6.27e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.72e-05	6.25e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.71e-05	6.23e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.7e-05	6.17e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.68e-05	6.11e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.64e-05	5.97e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.64e-05	5.97e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.63e-05	5.95e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.63e-05	5.95e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.62e-05	5.89e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.62e-05	5.89e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.61e-05	5.85e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.58e-05	5.74e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.54e-05	5.62e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.54e-05	5.61e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.54e-05	5.6e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.52e-05	5.55e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.51e-05	5.5e-05	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.41e-05	5.12e-05	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.4e-05	5.1e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.39e-05	5.07e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.39e-05	5.05e-05	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.39e-05	5.05e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.38e-05	5.04e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.38e-05	5.02e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.37e-05	5e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.37e-05	4.97e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.32e-05	4.79e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.31e-05	4.77e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-05	4.74e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.3e-05	4.73e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-05	4.72e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.28e-05	4.68e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.28e-05	4.65e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.27e-05	4.63e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.26e-05	4.59e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.21e-05	4.42e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.21e-05	4.41e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.21e-05	4.4e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.2e-05	4.36e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-05	4.3e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-05	4.29e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-05	4.25e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.17e-05	4.25e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.16e-05	4.22e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.12e-05	4.07e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-05	3.95e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.08e-05	3.94e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.07e-05	3.9e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.07e-05	3.9e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-05	3.87e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.06e-05	3.86e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.05e-05	3.82e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	8.99e-06	3.27e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.17e-06	2.97e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.14e-06	2.97e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.07e-06	2.94e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.54e-06	2.74e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.51e-06	2.74e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.44e-06	2.71e-05	CbGpPWpGaD
